Remnant-like particles and coronary artery disease in familial hypercholesterolemia

Hayato Tada1, Masa-Aki Kawashiri1, Atsushi Nohara1

  • 1Department of Cardiovascular and Internal Medicine, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.

Insights

Remnant-like particle cholesterol (RLP-C) is linked to coronary artery disease (CAD) in familial hypercholesterolemia (FH) patients. While RLP-C correlates with triglycerides, its independent association with CAD severity requires further investigation.

Area of Science:

  • Cardiology
  • Lipid Metabolism
  • Genetics

Background:

  • Remnant-like particle cholesterol (RLP-C) is a known risk factor for coronary artery disease (CAD) in the general population.
  • Limited data exist on the association between RLP-C and CAD specifically in patients with familial hypercholesterolemia (FH).

Purpose of the Study:

  • To investigate the association between serum RLP-C levels and the presence and severity of CAD in patients diagnosed with FH.

Main Methods:

  • A cohort of 282 FH patients (144 males, mean age 41 years) had their serum RLP-C levels measured.
  • Baseline characteristics, lipid profiles, cardiovascular risk factors, and the presence of CAD were assessed.
  • Logistic regression analysis was performed, adjusting for multiple confounding variables.

Main Results:

  • Serum RLP-C levels showed a significant positive correlation with serum triglyceride (TG) levels (r=0.631, p<0.001).
  • Higher RLP-C tertiles were associated with a greater number of diseased coronary arteries (p<0.001 trend).
  • Adjusted logistic regression indicated RLP-C was significantly associated with CAD (OR: 1.08, p=0.046), but this association was nullified when TG levels were included. Lipoprotein (a) [Lp(a)] remained independently associated with CAD (OR: 1.02, p=0.015).

Conclusions:

  • Serum RLP-C levels are significantly associated with both the presence and severity of CAD in FH patients.
  • The independent clinical utility of RLP-C measurement, beyond that of TG, warrants further evaluation in this population.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
519
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
302
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
422
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
734
Protein Families02:47

Protein Families

Protein families are groups of homologous proteins; that is, they have similarities in amino acid sequences and three-dimensional structures. Protein families usually occur because of gene duplication, where an additional copy of a gene is inserted into the genome of an organism.   Mutations that change the amino acids but still allow the protein to be properly synthesized, will lead to new protein family members.   If these new proteins contain similar amino acids in key...
17.2K